PMV Pharmaceuticals Inc. (PMVP)
1.40
0.05 (3.70%)
At close: Jan 15, 2025, 1:15 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -68.96M | -73.32M | -57.85M | -34.44M | -25.35M | -17.54M |
| Depreciation & Amortization | 1.26M | 315.00K | 307.00K | 318.00K | 388.00K | 338.00K |
| Stock-Based Compensation | 12.38M | 10.20M | 5.34M | 1.93M | 908.00K | 1.08M |
| Other Working Capital | 5.19M | -179.00K | 3.93M | 385.00K | 122.00K | 370.00K |
| Other Non-Cash Items | -5.76M | -385.00K | 955.00K | 143.00K | 8.00K | -13.00K |
| Deferred Income Tax | n/a | n/a | 550.00K | 152.00K | 62.00K | 319.00K |
| Change in Working Capital | 5.43M | -568.00K | 4.12M | -845.00K | 1.92M | 637.00K |
| Operating Cash Flow | -55.66M | -63.76M | -46.57M | -32.74M | -22.07M | -15.18M |
| Capital Expenditures | -962.00K | -7.98M | -1.35M | -148.00K | -109.00K | -452.00K |
| Acquisitions | n/a | -6.62K | 2.74M | 148.00K | -3.34K | n/a |
| Purchase of Investments | -220.54M | -229.20M | -256.85M | -14.51M | -43.45M | -48.68M |
| Sales Maturities Of Investments | 170.96M | 235.81M | 114.61M | 42.57M | 46.79M | 70.82M |
| Other Investing Acitivies | n/a | 6.62K | -2.74M | -148.00K | 3.34K | 22.14M |
| Investing Cash Flow | -50.55M | -1.37M | -143.58M | 27.91M | 3.23M | 21.69M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 912.00K | 958.00K | 2.02M | 69.80M | 61.80M | n/a |
| Financial Cash Flow | 35.58M | 958.00K | 2.02M | 292.97M | 61.80M | n/a |
| Net Cash Flow | -70.59M | -64.17M | -188.13M | 288.14M | 42.97M | 6.51M |
| Free Cash Flow | -56.62M | -71.74M | -47.92M | -32.89M | -22.17M | -15.63M |